Fase II study of carboplatin and vinorelbine in malignant pleural mesothelioma - Fase II MPM
- Conditions
- Patients with malignant pleural mesothelioma who cannot be operated
- Registration Number
- EUCTR2005-002223-14-DK
- Lead Sponsor
- Rigshospitalet
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
malignant pleural mesothelima
ps 0-2
age>18
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
poor organ function
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Efficacy<br>Response;Secondary Objective: survival<br>toxicity<br>QOL;Primary end point(s): response rate
- Secondary Outcome Measures
Name Time Method